Literature DB >> 8251206

Multiple hospital admissions in a calendar year.

J Newton1, M Goldacre.   

Abstract

Hospital in-patient workload is routinely measured as episodes of care. We report on the extent to which counts of episodes of care differ from counts of patients treated in different specialties and in different age groups. Linked records of hospital care in a population of 1.9 million people, collected over an 11-year period (1976-1986), were analysed. The all-ages multiple admission ratio (the number of admissions per 100 people admitted in the same specialty and year) varied between specialties from 102 to 171. Medical specialties tended to have higher ratios than surgical ones. The influence of age on multiple admission ratios varied between specialties, although in general the ratios increased with increasing age. There were progressive but small increases in multiple admission ratios over the period studied in a number of specialties but, by and large, stability over time was more striking than any change. The information presented could be used to estimate person-based admission rates from available episode-based data where the former are not available. This should be helpful both in managing hospital resources and in purchasing care on behalf of resident populations. Purchasers in particular should be aware of numbers of people being treated as well as the numbers of episodes of care provided.

Entities:  

Mesh:

Year:  1993        PMID: 8251206     DOI: 10.1007/bf02959668

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  8 in total

1.  EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products.

Authors: 
Journal:  Pharmacol Toxicol       Date:  1990-10

2.  [Glossary of the most important terms in the evaluation of treatments].

Authors:  J P Boissel
Journal:  Arch Mal Coeur Vaiss       Date:  1989-09

3.  Explanatory and pragmatic attitudes in therapeutical trials.

Authors:  D Schwartz; J Lellouch
Journal:  J Chronic Dis       Date:  1967-08

Review 4.  CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

Authors:  M Akhtar; G Breithardt; A J Camm; P Coumel; M J Janse; R Lazzara; R J Myerburg; P J Schwartz; A L Waldo; H J Wellens
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

5.  Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.

Authors:  W H Inman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

6.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

7.  ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

8.  Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.

Authors: 
Journal:  Am J Cardiol       Date:  1988-03-01       Impact factor: 2.778

  8 in total
  1 in total

1.  Geographical variation in hospital admission rates: an analysis of workload in the Oxford region, England.

Authors:  J N Newton; V Seagroatt; M Goldacre
Journal:  J Epidemiol Community Health       Date:  1994-12       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.